{"id":"W2978880457","doi":"10.1093/annonc/mdz394.065","title":"5-year survival outcomes of the CheckMate 067 phase III trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ipilimumab; Medicine; Nivolumab; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001713196,0.0006899817,0.001130593,0.0003500711,0.0003298894,0.00118185,0.0005845201,0.0008918861,0.002561763],"category_scores_gemma":[0.001100645,0.00023773,0.002037535,0.0003289077,0.0004341814,0.0007066648,0.0003522849,0.002124403,0.0004641668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008917145,"about_ca_system_score_gemma":0.0006839692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001233138,"about_ca_topic_score_gemma":0.003577719,"domain_scores_codex":[0.9994941,0.0002423267,0.00002445929,0.00008668578,0.00005565834,0.00009679762],"domain_scores_gemma":[0.9992713,0.0001776995,0.0001786276,0.00006008927,0.00004200704,0.0002701972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8066903,0.01005847,0.03301973,0.00099419,0.007442384,0.0001563942,0.000159969,0.008709624,0.01041257,0.0006249133,0.01171475,0.1100167],"study_design_scores_gemma":[0.3793752,0.3508307,0.2255591,0.0003163596,0.01358738,0.0006143392,0.0002592892,0.01002134,0.004501309,0.0015703,0.01322692,0.0001378491],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98891,0.005130837,0.0001833251,0.0004515251,0.0001786607,0.000191652,0.00201131,0.00003359899,0.002909098],"genre_scores_gemma":[0.9911345,0.001599413,0.0002553816,0.0006907507,0.000188585,0.0002370227,0.003498705,0.00001698534,0.0023786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002561763,"threshold_uncertainty_score":0.009060383,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08452269851717625,"score_gpt":0.4290534193977082,"score_spread":0.344530720880532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}